We are live on ! Find out more
KTOVW

Kitov Pharma Ltd. Warrants
KTOVW

Delisted

KTOVW was delisted on the 23rd of November, 2020.

Back to rankings

2 hedge funds and large institutions have $8K invested in Kitov Pharma Ltd. Warrants in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more capital invested

Capital invested by funds: $3K → $8K (+$5K)

100% more funds holding

Funds holding: 1 → 2 (+1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$8.03K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$2.37K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$7K +$8.03K +11,188 New
UBS Group
2
UBS Group
Switzerland
$1K -$2.37K -3,300 -63%

KTOVW Hedge Fund Activity: Q1 2018 in Review

2 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Kitov Pharma Ltd. Warrants (KTOVW) for Q1 2018, worth a combined $8K — up 167% from $3K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new KTOVW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $8.03K. The largest seller was UBS Group, cutting an estimated $2.37K.

  • 2 institutional investors held Kitov Pharma Ltd. Warrants (KTOVW) as of Q1 2018, up from 1 in Q4 2017.
  • Funds reported $8K of Kitov Pharma Ltd. Warrants stock for Q1 2018, up 167% quarter-over-quarter.
  • 1 fund opened new Kitov Pharma Ltd. Warrants positions in Q1 2018 and 0 closed out, a net change of +1 holder.
  • The largest Kitov Pharma Ltd. Warrants buyer in Q1 2018 was Susquehanna International Group, an estimated $8.03K added.
  • The largest Kitov Pharma Ltd. Warrants seller in Q1 2018 was UBS Group, an estimated $2.37K sold.

Based on aggregated 13F filings for Q1 2018.